Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jan 01, 2008 (Vol. 28, No. 1)

ClinLabNavigator.com – Clinical Laboratory Reference

  • Very good coverage
  • Doesn't help its audience very well
An excellent site has 1) useful information; 2) covers a topic with considerable interest to visitors; 3) is nicely organized; and 4) has a clear purpose. ClinLabNavigator.com bats about .750, in this respect, with a LOT of useful information about clinical lab tests. The topic of clinical lab info is certainly of interest to many people. In addition, the site is organized pretty well, with an alphabetical scheme that works reasonably well. With over 500 lab test interpretations to report on, the site covers its topic well. What the site, unfortunately doesn’t do is identify its target audience and help them to see what the site has to offer. Clearly, much of the information is aimed at the general public, but I’m sure their first impression of the site is that it is aimed at techie people. That’s very unfortunate and could be dealt with very simply on the opening page or via a simple “About this site” section. Ideally, the site could expand, providing technical info for professionals and general info for non-techie visitors. Hopefully that will happen soon.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »